Lymphokine activated killer cells: a new approach to immunotherapy of cancer.
Padua University School of Medicine, Department of Clinical Medicine, First Medical Clinic, Italy.
G
G
Semenzato
D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects; D007376:Interleukin-2 / Q000627:therapeutic use; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology*; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2